Introduction
Phospholipase C enzymes (PLCs, EC 3.1.4.3) catalyze the cleavage of phosphatidylinositol-4,5-bisphosphate (PIP 2 ) and result in the release of 1,2-diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP 3 ) from membranes in response to receptor activation. These products trigger the activation of protein kinase C and the release of Ca 2+ from intracellular stores, respectively [1, 2] . They are crucial for initiation of cellular activation, proliferation, differentiation and apoptosis. Until recently, five distinct classes of PLCs that specifically react with phosphatidylinositols were known to exist in mammals, the ␤ -, ␥ -, ␦ -, -and -type enzymes [3, 4] . They have been classified on the basis of amino acid sequence, domain structure and by the mechanisms through which they are recruited in response to activated receptors. We, along with several other groups, identified a sixth class that was termed PLC [5] [6] [7] [8] . Two putative PLC enzymes were identified in humans and mice, PLC 1 and PLC 2 [5] and both have been confirmed to catalyze hydrolysis of PIP 2 [6] [7] [8] suggesting that PLC s, like other PLCs, are involved in the production of the secondary messengers DAG and IP 3 .
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Domain Structure of PLC Enzymes
Like other mammalian PLCs, the domain structure of PLC s consists of pleckstrin homology (PH), EF-hand, catalytic X and Y domains and protein kinase C conserved region 2 (C2). Figure 1 a shows the domain organization of all mammalian PLC isozymes including all known forms of PLC . The PH domain ( ϳ 110 residues; absent in PLC ) binds polyphosphoinositides [9] and is present in many signalling proteins that associate with phospholipid membranes [10, 11] . This domain is not essential for membrane localization of PLC ␦ 1 and PLC ␦ 4 [6, 12] but appears to be important for membrane localization of PLC 2. Approximately 85% of native PLC 2 and 97% of FLAG-tagged PLC 2 constructs were found to associate with the plasma membrane, whereas only 6% of a PLC 2 construct with the PH domain removed was present at the cell surface [6] . The role of the EF hand domain ( ϳ 65 residues) in PLCs is unclear, but the X-ray structure of PLC ␦ 1 shows that it serves as a flexible 'hinge-like' link between the PH and the catalytic domains [13] . The X and Y domains ( ϳ 150 and ϳ 115 residues, respectively) fold to form the catalytic site. The X domain is involved in both substrate and Ca 2+ binding (which is essential for catalysis), while the Y domain primarily interacts with the substrate [13] . These regions contain the highest degree of sequence identity (between 60 and 85%) among different mammalian PLCs [14] . The C2 domain is essential for catalytic activity and may contain as many as four Ca 2+ -binding sites [15] and is often present in proteins that interact with phospholipids. In some PLCs the C2 domain binds Ca 2+ and mediates Ca 2+ -dependent interactions with the lipid membrane; however, it has also been shown that Ca 2+ can induce dimerization of proteins which contain this domain [16] . PLC s share a close evolutionary relationship with other PLC isozymes and are most closely related to the PLC ␦ class [5, 6] . However, unlike PLC ␦ s, the PLC enzymes contain an extended loop ( ϳ 100 residues longer) between the X and Y domains and also include an additional C-terminal region that is rich in serine and proline residues. Serine-and proline-rich regions are thought to have roles in protein-protein interactions [17, 18] . The C-terminal regions of PLC s are likely to be functional, but this has yet to be determined.
PLC s also contain a class II PDZ (post-synaptic density protein, Drosophila disc large tumour suppressor, and zo-1 protein) conserved binding motif (PDZCBM; ⌿ X ⌿ -COOH, where ⌿ represents a hydrophobic residue) at the C-terminus. PLC ␤ s also contain a PDZCBM albeit a different motif (class I; (S/T)X(L/V)-COOH) and have been shown to be involved in the formation of multiprotein scaffolds including the InaD complex which mediates the assembly of photoreceptors via TRP (transient receptor potential) channel activation [19, 20] and the Na + /H + exchanger regulatory factor 1-assembled complex in the kidney [21] . It is therefore likely that in addition to classical PLC signalling PLC s, like PLC ␤ s, play a role in the formation of PDZ multi-protein complexes.
Three splice variants of PLC 1 and five splice variants of PLC 2 have been identified, all of which differ in length in the C-terminal region. The three variants of PLC 1, 'a', 'b' and 'c' encode human proteins of 1,002, 1,693 and 1,035 amino acids, respectively [7] . Interestingly, all three variants contain class II PDZCBM, although the actual sequence of the motif for PLC 1a (VQI-COOH) differs from that of PLC 1b and PLC 1c (LRL-COOH). This hints that variant 'a' may function as part of a different PDZ protein-scaffold than the other two variants. The five PLC 2 variants encode human proteins of 1,416, 989, 1,583, 1,156 and 1,211 amino acids and have been categorised according to the exon structure of the spliced forms: '21a/23', '21a/22/23', '21b/23', '21b/22/23' and '21c/22/23', respectively [8] . Of these five variants, only two ('21a/23' and '21b/23') contain a class II PDZCBM (both LRL-COOH), whilst the other three variants do not contain a PDZCBM at all. This again suggests the potential for differing functions between spliced forms in vivo.
Expression of PLC Enzymes in Neural and Neuroendocrine Cells
Murine PLC 1 expression has been investigated by RT-PCR using primer pairs targeting a common region of the three splice variants and also for the PLC 1a variant only [7] . In the range of tissues examined, the PCR products of the common region were most abundant in brain and kidney but were also observed in lung, spleen, intestine, thymus and pancreas. PLC 1a was detected in the brain and lung only. Immunoblotting confirmed expression of PLC 1a protein in neuronal tissues such as cerebrum, cerebellum and spinal cord. In situ hybridization revealed a high level of expression in neuronal cell bodies within the inner layer of the olfactory bulb, the hippo-campus, Purkinje layer of cerebellum, cerebral cortex, zona incerta, habenular nuclei and hypothalamus [7] . RT-PCR and Northern blot analyses have shown that PLC 2 gene expression is detectable in both brain and intestine of mice [5, 6] . In addition, expressed sequence tags (ESTs) corresponding to human PLC 2 were identified in cDNAs isolated from a range of neuron-rich tissues including anaplastic oligodendroglioma, epithelioid carcinoma, leukopheresis, lymph, nerve tumour, optic nerve, pancreatic islet, pituitary and retinoblastoma cell populations [5] . Immunoblot analysis detected PLC 2 expression in the brain but not in a variety of other murine tissues including small intestine, heart, skeletal muscle, kidney, liver, lung, testis or spleen [6] . Expression of PLC 2 protein in the brain was found to be developmentally dependent, being detectable 1-2 weeks after birth. It was also detected at high levels in neuroncontaining primary cultures but not in astrocyte cultures. In situ hybridization on murine tissue sections showed gene expression in pyramidal cells of the olfactory bulb, hippocampus and cerebral cortex, three regions where PLC 1 is also expressed.
The hippocampus and cerebral cortex are involved in memory and learning [22, 23] . The olfactory bulb functions in odour and pheromone perception and is also involved in neuro-hormonal programming of the hypothalamo-pituitary axis [24, 25] . PLC enzymes may therefore play a role in neural signalling pertaining to memory and learning or neuro-hormonal regulation. This hypothesis is consistent with the observation that PLC 2 increases with postnatal age. In addition, PLC 2 was found to have a very similar expression pattern to that of neuron marker protein, microtubule-associated protein 2 (MAP2) [6] . This suggests that PLC 2 is particularly likely to be involved in some aspect of neural or neuroendocrine functioning.
Further evidence that PLC 2 may play a role in the hypothalamo-pituitary axis has come from recent work in our laboratory where we have found various splice variants of this protein are present in the GT17 gonadotropin-releasing hormone (GnRH) neuronal cell line, RAT1 fibroblast cells and in the L ␤ T2, ␣ T3, GH3 and AtT20 pituitary cell lines but not in HEK293 or COS7 kidney cells, C6 glial cells or B35 neurons ( fig. 1 b) . The GT17 cell line is a well-characterised model of the hypothalamic GnRH neuron and secretes GnRH in a pulsatile manner in culture [26] . L ␤ T2 and ␣ T3 cells are pituitary gonadotrope-like cells, which express GnRH receptor. The L ␤ T2 cell line can be stimulated to release the pituitary hormones luteinising hormone and follicle stimulating hormone [27, 28] . The other pituitary cell lines found to express PLC 2 were the AtT20 cells, which are able to produce adrenocorticotropic hormone [29] and GH3 cells, which secrete prolactin [30] . Interestingly, PLC 2 was also detected in RAT1 fibroblasts. Transformed fibroblast populations have previously been shown to have CD63-positive endosomes resembling the granular secretory cores typical of neuroendocrine cells 3 . These products stimulate Ca 2+ release and PKC activation. In vivo PLC 2 may undergo receptor-mediated activation via interaction with G ␤ ␥ or in response to a small elevation in levels of cytoplasmic Ca 2+ . PLC s may also be involved in vesicle exocytosis through association with PDZ protein scaffolds. [31] . Given the presence of PLC 2 in these pituitary neuroendocrine cells as well as neuron-rich regions of the brain, this protein may have a possible role in vesicle exocytosis. A process which is not only Ca 2+ -driven but requires formation of pre-synaptic PDZ domain-protein complexes at the surface of the cell membrane [32, 33] .
Regulation and Function
In the recent study by Zhou et al. [8] , co-expression of PLC 2 with the G proteins, G ␤ 1 and G ␥ 2 resulted in elevated PLC activity in COS-7 cells. This suggests that PLC 2 may be activated in response to G protein-coupled receptor activation. G ␤ ␥ dimers have also been shown to activate PLC ␤ 1-3 and PLC [34] [35] [36] through interaction with the PH domain [37] . Whether the observed G ␤ ␥ -mediated stimulation of PLC activity in PLC 2 is a direct or indirect effect remains to be examined. However, sequence analysis reveals that several key residues in the PH domain of bovine glycogen synthase kinase 2 that are known to directly bind G ␤ ␥ are conserved. These include Arg587 (which corresponds to Arg78 in PLC 2) and is essential for G ␤ ␥ -induced activation of this enzyme [38] .
All PLC isozymes can be activated by Ca 2+ in vitro, but PLC ␦ 1 is more sensitive to Ca 2+ compared with the other isozymes and it can be constitutively tethered to PIP 2 -containing membranes via its PH domain in the absence of other signals [39] . It has therefore been speculated that an increase in the intracellular Ca 2+ to a level sufficient to fix the C2 domain of PLC ␦ 1 to the membrane triggers its activation [39] . Thus, it has been postulated that activation of PLC ␦ 1 isozymes may occur following receptormediated activation of other PLC isozymes [40] . Interestingly, PLC 1 and PLC 2 exhibit Ca 2+ -dependent (PIP 2 )-hydrolyzing activity in vitro but differ greatly, compared with other PLCs, in their sensitivity toward Ca
2+
. Both enzymes display maximal activity at a Ca 2+ concentration of ϳ 1 M [6, 7] , which is at least 10-fold lower than that required by PLC ␦ 1 [6] . Increased sensitivity means that PLC s may catalyse PIP 2 hydrolysis at much lower Ca 2+ concentrations than PLC ␦ 1 in vivo and indicate that like the PLC ␦ class, PLC 2 may not necessarily be linked to receptor-mediated activation. Alternatively, this enzyme may amplify the signalling events of other PLCs or even Ca 2+ channels. A speculative representation of PLC signalling is shown in figure 2 . Kinetic analyses for either of the PLC enzymes have yet to be performed, but it would be interesting to determine whether PIP 2 hydrolysis occurs at a comparable or faster rate than other PLC enzymes under physiological conditions. If so, PLC 2 may facilitate very rapid communication between cells due to its elevated Ca 2+ sensitivity.
Analysis of the Ca 2+ -mediated lipid-binding site in the C2 domain of synaptotagmin I (a Ca 2+ -activated vesicle protein) shows that it consists of four aspartate residues, Asp172, Asp178, Asp230 and Asp232 [41] . All four of these residues are conserved in the C2 domain of the PLC enzymes but not in PLC ␦ 1, where Asp172 is equivalent to Asn645 [42] . Ca 2+ ions would therefore be expected to bind more tightly at this site in synaptotagmin I and the PLC s than to PLC ␦ 1. This may explain the greater Ca 2+ sensitivity exhibited by PLC s. Other PLCs such as the PLC ␤ and PLC ␥ enzymes also contain a C2 domain, yet here the key residues involved in Ca 2+ binding are not conserved [43] .
In conclusion, PLC enzymes represent an exciting new discovery in the field of neurophysiology and molecular data suggests the basis for their involvement in novel protein networks relaying Ca 2+ signalling and protein kinase C activation. Such networks are likely to be of great importance in the brain and neuroendocrine tissues. Our recent data suggest that neuroendocrine cell lines may be appropriate tools to begin examining the cell biology of PLC s. It is hoped that these findings stimulate further research towards elucidating their physiological function.
